Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Kelly Perlman, BSc, 2018, Research Associate, LPBI Group’s BioMed e-Series published on Amazon.com

Roles at LPBI Group in 2016:

• Research Associate,
• Content Digitization,
• Complex Proof Reading, and
• Format Conversion, BioMed e-Series published on Amazon.com

Areas of Interest in Life Sciences

1. Neuroscience
2. Medical Imaging Technology
3. Image Processing/Computing
4. Human Aging
5. Cerebrovascular and Neurodegenerative Diseases
6. Neurological Diseases
7. Computational Biology/Systems Bioinformatics
8. Cell Biology Signaling and Cell Circuits
9. Autoimmune Inflammatory Diseases
10. Human Immune System in Disease and Health
11. Cognition
12. Artificial Intelligence

Contributions completed for LPBI Group

#1  Research Associate for BioMed BioMed e-Series published on Amazon.com, 2016

• Content Digitization,
• Complex Proof Reading, and
• Format Conversion

Series C: Cancer Volume Two: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery 

https://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/volume-2-immunotherapy-in-oncology/

#2  Article Published in Pharmaceuticalintelligence.com

Crowdsourcing Genetic Data Yields Discovery of DNA loci associated with Major Depressive Disorder (MDD) in European Descendants

Reporter: Kelly Perlman, Life Sciences Student and Research Assistant, McGill University

https://pharmaceuticalintelligence.com/2016/08/09/crowdsourcing-genetic-data-yields-discovery-of-dna-loci-associated-with-mdd-in-european-descendants/

Kelly Perlman

Degree: BSc (in progress)

Specialty: Life Sciences

e-Mail: kelly.perlman@mail.mcgill.ca

Affiliation: McGill University

LinkedIn Profile

https://ca.linkedin.com/in/kelly-perlman-aa2a74132